vimseltinib
deciphera
['vimseltinib', 'deciphera']
deciphera pharmaceuticals, inc. presents updated phase 1/2 data for vimseltinib in tgct at the european society for medical oncology (esmo) congress 2022 #stocksmarket #pressrelease
Stock Market News and Press Releases. #StockMarket & #Crypto